CVS Health is a different kind of health care company. It is a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, it is meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, its diversified model engages one in three Americans each year. From its innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, it is making health care more accessible, more affordable and simply better.
Company profile
Ticker
CVS
Exchange
Website
CEO
Larry Merlo
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
CVS CAREMARK CORP, CVS CORP, CVS/CAREMARK CORP, MELVILLE CORP
SEC CIK
Corporate docs
Subsidiaries
CVS Foreign, Inc. • ◦CVS Caremark Indemnity Ltd. • ◦CVS International, L.L.C. • CVS Pharmacy, Inc. • Aetna Inc. • ◦Aetna Health Holdings, LLC • ◦Aetna Health of California Inc. • ◦Aetna Health Inc. • ◦Aetna Health of Michigan Inc. • ▪Aetna Better Health Inc. ...
IRS number
50494040
CVS stock data
Analyst ratings and price targets
Latest filings (excl ownership)
DFAN14A
Additional proxy materials by non-management
7 Mar 23
8-K
Other Events
21 Feb 23
8-K
Other Events
15 Feb 23
424B2
Prospectus for primary offering
15 Feb 23
FWP
Free writing prospectus
13 Feb 23
424B3
Prospectus supplement
13 Feb 23
DFAN14A
Additional proxy materials by non-management
8 Feb 23
8-K
Form of Voting and Support Agreement
8 Feb 23
DFAN14A
Additional proxy materials by non-management
8 Feb 23
10-K
2022 FY
Annual report
8 Feb 23
Transcripts
CVS
Earnings call transcript
2022 Q4
8 Feb 23
CVS
Earnings call transcript
2022 Q3
2 Nov 22
CVS
Earnings call transcript
2022 Q2
3 Aug 22
CVS
Earnings call transcript
2022 Q1
4 May 22
CVS
Earnings call transcript
2021 Q4
9 Feb 22
CVS
Earnings call transcript
2021 Q3
3 Nov 21
CVS
Earnings call transcript
2021 Q2
4 Aug 21
CVS
Earnings call transcript
2021 Q1
4 May 21
CVS
Earnings call transcript
2020 Q4
16 Feb 21
CVS
Earnings call transcript
2020 Q3
6 Nov 20
Latest ownership filings
4
Prem S Shah
1 Mar 23
4
MICHELLE A PELUSO
1 Mar 23
4
Samrat S. Khichi
1 Mar 23
4
J. David Joyner
1 Mar 23
4
Laurie P. Havanec
1 Mar 23
4
James David Clark
1 Mar 23
4
Sreekanth K Chaguturu
1 Mar 23
3
Samrat S. Khichi
15 Feb 23
13F-HR
Quarterly holdings report by institutional manager
10 Feb 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 13.31 bn | 13.31 bn | 13.31 bn | 13.31 bn | 13.31 bn | 13.31 bn |
| Cash burn (monthly) | 1.42 bn | (no burn) | (no burn) | (no burn) | 650.67 mm | (no burn) |
| Cash used (since last report) | 4.04 bn | n/a | n/a | n/a | 1.85 bn | n/a |
| Cash remaining | 9.27 bn | n/a | n/a | n/a | 11.46 bn | n/a |
| Runway (months of cash) | 6.5 | n/a | n/a | n/a | 17.6 | n/a |
Institutional ownership, Q4 2022
79.8% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 2313 |
| Opened positions | 214 |
| Closed positions | 155 |
| Increased positions | 911 |
| Reduced positions | 960 |
| 13F shares | Current |
|---|---|
| Total value | 94.88 tn |
| Total shares | 1.02 bn |
| Total puts | 11.25 mm |
| Total calls | 14.50 mm |
| Total put/call ratio | 0.8 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 117.53 mm | $10.95 tn |
| BLK Blackrock | 94.97 mm | $8.85 tn |
| STT State Street | 57.88 mm | $5.39 tn |
| Capital World Investors | 56.54 mm | $5.27 tn |
| MS Morgan Stanley | 33.58 mm | $3.13 tn |
| JPM JPMorgan Chase & Co. | 26.69 mm | $2.49 tn |
| Capital International Investors | 26.05 mm | $2.43 tn |
| Geode Capital Management | 23.33 mm | $2.17 tn |
| BAC Bank Of America | 18.40 mm | $1.71 tn |
| IVZ Invesco | 15.68 mm | $1.46 tn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Feb 23 | Khichi Samrat S. | Common Stock (Restricted) | Grant | Acquire A | No | No | 83.54 | 47,881 | 4.00 mm | 47,881 |
| 28 Feb 23 | J. David Joyner | Common Stock (Restricted) | Grant | Acquire A | No | No | 83.54 | 23,940 | 2.00 mm | 23,940 |
| 28 Feb 23 | James David Clark | Common Stock | Payment of exercise | Dispose F | No | No | 83.54 | 179 | 14.95 k | 26,151.255 |
| 27 Feb 23 | Prem S Shah | Common Stock | Payment of exercise | Dispose F | No | No | 85.77 | 226 | 19.38 k | 44,403.32 |
| 27 Feb 23 | Michelle A Peluso | Common Stock | Payment of exercise | Dispose F | No | No | 85.77 | 12,304 | 1.06 mm | 222,682 |
Press releases
CVS Health announces quarterly dividend
16 Mar 23
OAK STREET HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oak Street Health, Inc. - OSH
9 Feb 23
SHAREHOLDER ALERT: Weiss Law Investigates Oak Street Health, Inc.
8 Feb 23
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Oak Street Health (OSH)
8 Feb 23
CVS HEALTH REPORTS STRONG FOURTH QUARTER AND FULL-YEAR 2022 RESULTS
8 Feb 23